Skip to main content
Erschienen in: neurogenetics 2/2012

01.05.2012 | Original Article

JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family

verfasst von: Susanne A. Schneider, Kate E. Marshall, Jianfeng Xiao, Mark S. LeDoux

Erschienen in: Neurogenetics | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

We report the clinical, neuropsychological, genetic, and radiological features of a large five-generation African-American kindred from the southern USA presenting with a progressive akinetic-rigid syndrome and severe dementia, but clinically insignificant chorea, due to mutations in junctophillin 3 (JPH3). Overt disease onset was in the mid-20s to late 30s with cognitive decline, REM sleep disturbance, or psychiatric features, followed by development of a levodopa-unresponsive akinetic-rigid motor syndrome. Dystonia and myoclonus were present in some subjects. A bedridden, nonverbal severely akinetic-rigid state developed within 10 to 15 years after onset. CTG repeat expansions ranged from 47 to 53. Imaging revealed generalized cerebral atrophy with severe striatal involvement and putaminal rim hyperintensity. Analysis of our kindred indicates that JPH3 mutations should be considered in the differential diagnosis of early-onset dementia and hypokinetic-rigid syndromes in individuals of African descent. Moreover, chorea may not be overtly manifest at presentation or during significant parts of the disease course.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Margolis RL, O'Hearn E, Rosenblatt A, Willour V, Holmes SE, Franz ML, Callahan C, Hwang HS, Troncoso JC, Ross CA (2001) A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion. Ann Neurol 50:373–380 Margolis RL, O'Hearn E, Rosenblatt A, Willour V, Holmes SE, Franz ML, Callahan C, Hwang HS, Troncoso JC, Ross CA (2001) A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion. Ann Neurol 50:373–380
2.
Zurück zum Zitat Margolis RL, Rudnicki DD, Holmes SE (2005) Huntington's disease like-2: review and update. Acta Neurol Taiwan 14:1–8PubMed Margolis RL, Rudnicki DD, Holmes SE (2005) Huntington's disease like-2: review and update. Acta Neurol Taiwan 14:1–8PubMed
3.
Zurück zum Zitat Greenstein PE, Vonsattel JP, Margolis RL, Joseph JT (2007) Huntington's disease like-2 neuropathology. Mov Disord 22:1416–1423PubMedCrossRef Greenstein PE, Vonsattel JP, Margolis RL, Joseph JT (2007) Huntington's disease like-2 neuropathology. Mov Disord 22:1416–1423PubMedCrossRef
4.
Zurück zum Zitat Rudnicki DD, Pletnikova O, Vonsattel JP, Ross CA, Margolis RL (2008) A comparison of Huntington disease and Huntington disease-like 2 neuropathology. J Neuropathol Exp Neurol 67:366–374PubMedCrossRef Rudnicki DD, Pletnikova O, Vonsattel JP, Ross CA, Margolis RL (2008) A comparison of Huntington disease and Huntington disease-like 2 neuropathology. J Neuropathol Exp Neurol 67:366–374PubMedCrossRef
5.
Zurück zum Zitat Penney JB Jr, Young AB, Shoulson I, Starosta-Rubenstein S, Snodgrass SR, Sanchez-Ramos J, Ramos-Arroyo M, Gomez F, Penchaszadeh G, Alvir J et al (1990) Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 5:93–99PubMedCrossRef Penney JB Jr, Young AB, Shoulson I, Starosta-Rubenstein S, Snodgrass SR, Sanchez-Ramos J, Ramos-Arroyo M, Gomez F, Penchaszadeh G, Alvir J et al (1990) Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 5:93–99PubMedCrossRef
6.
Zurück zum Zitat García Ruiz PJ, Hernández J, Cantarero S, Bartolomé M, Sánchez Bernardos V, García de Yébenez J (2002) Bradykinesia in Huntington's disease. A prospective, follow-up study. J Neurol 249:437–440PubMedCrossRef García Ruiz PJ, Hernández J, Cantarero S, Bartolomé M, Sánchez Bernardos V, García de Yébenez J (2002) Bradykinesia in Huntington's disease. A prospective, follow-up study. J Neurol 249:437–440PubMedCrossRef
7.
Zurück zum Zitat Bardien S, Abrahams F, Soodyall H, van der Merwe L, Greenberg J, Brink T, Carr J (2007) A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features. Mov Disord 22:2083–2089PubMedCrossRef Bardien S, Abrahams F, Soodyall H, van der Merwe L, Greenberg J, Brink T, Carr J (2007) A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features. Mov Disord 22:2083–2089PubMedCrossRef
8.
Zurück zum Zitat Becker N, Munhoz RP, Raskin S, Cesar W, Teive HA (2007) Non-choreic movement disorders as initial manifestations of Huntington's disease. Arq Neuro-Psiquiatr 65:402–405CrossRef Becker N, Munhoz RP, Raskin S, Cesar W, Teive HA (2007) Non-choreic movement disorders as initial manifestations of Huntington's disease. Arq Neuro-Psiquiatr 65:402–405CrossRef
9.
Zurück zum Zitat Ross CA, Margolis RL (2001) Huntington's disease. Clin Neurosci Res 1:142–152CrossRef Ross CA, Margolis RL (2001) Huntington's disease. Clin Neurosci Res 1:142–152CrossRef
10.
Zurück zum Zitat Loy CT, Sweeney MG, Davis MB, Wills AJ, Sawle GV, Lees AJ, Tabrizi SJ (2005) Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging. Mov Disord 20:1521–1523PubMedCrossRef Loy CT, Sweeney MG, Davis MB, Wills AJ, Sawle GV, Lees AJ, Tabrizi SJ (2005) Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging. Mov Disord 20:1521–1523PubMedCrossRef
11.
Zurück zum Zitat Bech S, Petersen T, Nørremølle A, Gjedde A, Ehlers L, Eiberg H, Hjermind LE, Hasholt L, Lundorf E, Nielsen JE (2010) Huntington's disease like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation. Parkinsonism Relat Disord 16:12–15PubMedCrossRef Bech S, Petersen T, Nørremølle A, Gjedde A, Ehlers L, Eiberg H, Hjermind LE, Hasholt L, Lundorf E, Nielsen JE (2010) Huntington's disease like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation. Parkinsonism Relat Disord 16:12–15PubMedCrossRef
12.
Zurück zum Zitat Pasco PM, Ison CV, Muňoz EL, Magpusao NS, Cheng AE, Tan KT, Lo RW, Teleg RA, Dantes MB, Borres R, Maranon E, Demaisip C, Reyes MV, Lee LV (2011) Understanding XDP through imaging, pathology, and genetics. Int J Neurosci 121(Suppl 1):12–17PubMedCrossRef Pasco PM, Ison CV, Muňoz EL, Magpusao NS, Cheng AE, Tan KT, Lo RW, Teleg RA, Dantes MB, Borres R, Maranon E, Demaisip C, Reyes MV, Lee LV (2011) Understanding XDP through imaging, pathology, and genetics. Int J Neurosci 121(Suppl 1):12–17PubMedCrossRef
13.
Zurück zum Zitat Stevanin G, Camuzat A, Holmes SE, Julien C, Sahloul R, Dodé C, Hahn-Barma V, Ross CA, Margolis RL, Durr A, Brice A (2002) CAG/CTG repeat expansions at the Huntington's disease-like 2 locus are rare in Huntington's disease patients. Neurology 58:965–967PubMed Stevanin G, Camuzat A, Holmes SE, Julien C, Sahloul R, Dodé C, Hahn-Barma V, Ross CA, Margolis RL, Durr A, Brice A (2002) CAG/CTG repeat expansions at the Huntington's disease-like 2 locus are rare in Huntington's disease patients. Neurology 58:965–967PubMed
14.
Zurück zum Zitat Stevanin G, Fujigasaki H, Lebre AS, Camuzat A, Jeannequin C, Dode C, Takahashi J, San C, Bellance R, Brice A, Durr A (2003) Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 126:1599–1603PubMedCrossRef Stevanin G, Fujigasaki H, Lebre AS, Camuzat A, Jeannequin C, Dode C, Takahashi J, San C, Bellance R, Brice A, Durr A (2003) Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 126:1599–1603PubMedCrossRef
15.
Zurück zum Zitat Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP, Rossor MN, Davis MB, Tabrizi SJ (2008) Huntington's disease phenocopies are clinically and genetically heterogeneous. Mov Disord 23:716–720PubMedCrossRef Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP, Rossor MN, Davis MB, Tabrizi SJ (2008) Huntington's disease phenocopies are clinically and genetically heterogeneous. Mov Disord 23:716–720PubMedCrossRef
16.
Zurück zum Zitat Bauer I, Gencik M, Laccone F, Peters H, Weber BH, Feder EH, Weirich H, Morris-Rosendahl DJ, Rolfs A, Gencikova A, Bauer P, Wenning GK, Epplen JT, Holmes SE, Margolis RL, Ross CA, Riess O (2002) Trinucleotide repeat expansions in the junctophilin-3 gene are not found in Caucasian patients with a Huntington's disease-like phenotype. Ann Neurol 51:662PubMedCrossRef Bauer I, Gencik M, Laccone F, Peters H, Weber BH, Feder EH, Weirich H, Morris-Rosendahl DJ, Rolfs A, Gencikova A, Bauer P, Wenning GK, Epplen JT, Holmes SE, Margolis RL, Ross CA, Riess O (2002) Trinucleotide repeat expansions in the junctophilin-3 gene are not found in Caucasian patients with a Huntington's disease-like phenotype. Ann Neurol 51:662PubMedCrossRef
18.
Zurück zum Zitat Krause A, Hetem C, Holmes SE, Margolis RL (2005) HDL2 mutations are an important cause of Huntington's disease in patients with African ancestry. J Neurol Neurosurg Psychiatry 76:A16–A26 Krause A, Hetem C, Holmes SE, Margolis RL (2005) HDL2 mutations are an important cause of Huntington's disease in patients with African ancestry. J Neurol Neurosurg Psychiatry 76:A16–A26
19.
Zurück zum Zitat Walker RH, Rasmussen A, Rudnicki D, Holmes SE, Alonso E, Matsuura T, Ashizawa T, Davidoff-Feldman B, Margolis RL (2003) Huntington's disease—like 2 can present as chorea-acanthocytosis. Neurology 61:1002–1004PubMed Walker RH, Rasmussen A, Rudnicki D, Holmes SE, Alonso E, Matsuura T, Ashizawa T, Davidoff-Feldman B, Margolis RL (2003) Huntington's disease—like 2 can present as chorea-acanthocytosis. Neurology 61:1002–1004PubMed
20.
Zurück zum Zitat Santos C, Wanderley H, Vedolin L, Pena SD, Jardim L, Sequeiros J (2008) Huntington disease-like 2: the first patient with apparent European ancestry. Clin Genet 73:480–485PubMedCrossRef Santos C, Wanderley H, Vedolin L, Pena SD, Jardim L, Sequeiros J (2008) Huntington disease-like 2: the first patient with apparent European ancestry. Clin Genet 73:480–485PubMedCrossRef
21.
Zurück zum Zitat Rodrigues GG, Walker RH, Brice A, Cazeneuve C, Russaouen O, Teive HA, Munhoz RP, Becker N, Raskin S, Werneck LC, Junior WM, Tumas V (2008) Huntington's disease-like 2 in Brazil—report of 4 patients. Mov Disord 23:2244–2247PubMedCrossRef Rodrigues GG, Walker RH, Brice A, Cazeneuve C, Russaouen O, Teive HA, Munhoz RP, Becker N, Raskin S, Werneck LC, Junior WM, Tumas V (2008) Huntington's disease-like 2 in Brazil—report of 4 patients. Mov Disord 23:2244–2247PubMedCrossRef
Metadaten
Titel
JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family
verfasst von
Susanne A. Schneider
Kate E. Marshall
Jianfeng Xiao
Mark S. LeDoux
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Neurogenetics / Ausgabe 2/2012
Print ISSN: 1364-6745
Elektronische ISSN: 1364-6753
DOI
https://doi.org/10.1007/s10048-012-0318-9

Weitere Artikel der Ausgabe 2/2012

neurogenetics 2/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.